These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8465453)

  • 1. [Serology in patients with scleroderma].
    Ullman S; Halberg P; Høier-Madsen M; Kang L; Konstantinov K; Pedersen K; Rasmussen E; Wiik A
    Ugeskr Laeger; 1993 Feb; 155(7):472-6. PubMed ID: 8465453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives.
    Harvey G; Black C; Maddison P; McHugh N
    J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of anti-centromere and anti-Scl 70 antibodies in scleroderma. Report of two cases.
    Ruffatti A; Calligaro A; Ferri C; Bombardieri S; Gambari PF; Todesco S
    J Clin Lab Immunol; 1985 Apr; 16(4):227-9. PubMed ID: 3874966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary manifestation of progressive systemic scleroderma: prognostic value of centromere antibodies and antibodies to Scl-70 nucleoprotein].
    Behr J; König G; Meurer M; Krieg T
    Pneumologie; 1990 Jun; 44(6):822-5. PubMed ID: 2381889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous and serologic subsets of systemic sclerosis.
    Ferri C; Bernini L; Cecchetti R; Latorraca A; Marotta G; Pasero G; Neri R; Bombardieri S
    J Rheumatol; 1991 Dec; 18(12):1826-32. PubMed ID: 1795320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nuclear antibodies as serologic markers in progressive systemic scleroderma].
    Lakomek HJ; Guldner HH; Bautz FA; Goerz G; Kind P; Mensing H; Krüskemper HL
    Hautarzt; 1987 Feb; 38(2):63-9. PubMed ID: 3106261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Centromere antibodies and antibodies against Scl 70 nucleoprotein in progressive systemic scleroderma. Diagnostic and prognostic significance].
    Meurer M; Scharf A; Luderschmidt C; Braun-Falco O
    Dtsch Med Wochenschr; 1985 Jan; 110(1):8-14. PubMed ID: 3880700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma.
    Satoh M; Akizuki M; Kuwana M; Mimori T; Yamagata H; Yoshida S; Homma M; Yamamoto T; Sasazuki T
    J Rheumatol; 1994 Jan; 21(1):111-4. PubMed ID: 8151564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma).
    Reimer G
    Rheum Dis Clin North Am; 1990 Feb; 16(1):169-83. PubMed ID: 2406806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
    Vázquez-Abad D; Grodzicky T; Senécal JL
    Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological markers of the subsets of systemic scleroderma and its overlap.
    Jabłońska S; Błaszczyk M; Jarzabek-Chorzelska M; Chorzelski T; Kołacińska-Strasz Z
    Arch Immunol Ther Exp (Warsz); 1991; 39(4):381-90. PubMed ID: 1821614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients.
    Franceschini F; Cavazzana I; Generali D; Quinzanini M; Viardi L; Ghirardello A; Doria A; Cattaneo R
    J Rheumatol; 2002 Jul; 29(7):1393-7. PubMed ID: 12136894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights.
    Mahler M; Raijmakers R
    Autoimmun Rev; 2007 Aug; 6(7):432-7. PubMed ID: 17643929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies.
    Reveille JD; Solomon DH;
    Arthritis Rheum; 2003 Jun; 49(3):399-412. PubMed ID: 12794797
    [No Abstract]   [Full Text] [Related]  

  • 18. A highly conserved 72,000 dalton centromeric antigen reactive with autoantibodies from patients with progressive systemic sclerosis.
    McNeilage LJ; Whittingham S; McHugh N; Barnett AJ
    J Immunol; 1986 Oct; 137(8):2541-7. PubMed ID: 3531335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical relevance of autoantibodies in scleroderma.
    Ho KT; Reveille JD
    Arthritis Res Ther; 2003; 5(2):80-93. PubMed ID: 12718748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis.
    Akimoto S; Ishikawa O; Tamura T; Miyachi Y
    Br J Dermatol; 1996 Mar; 134(3):407-10. PubMed ID: 8731661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.